Amelioration of experimental autoimmune encephalomyelitis by clozapine is not associated with defective CD4 T cell responses
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Amelioration of experimental autoimmune encephalomyelitis by clozapine is not associated with defective CD4 T cell responses ; volume:14 ; number:1 ; day:29 ; month:3 ; year:2017 ; pages:1-10 ; date:12.2017
Journal of neuroinflammation ; 14, Heft 1 (29.3.2017), 1-10, 12.2017
- Schlagwort
-
Immunologie
Immunsystem
Lymphozyt
Leukozyt
Immunität
Resistenz
Immunchemie
- Urheber
-
Zareie, Pirooz
- Beteiligte Personen und Organisationen
-
Connor, Bronwen
La Flamme, Anne Camille
SpringerLink (Online service)
- DOI
-
10.1186/s12974-017-0842-5
- URN
-
urn:nbn:de:1111-2017041613939
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zareie, Pirooz
- Connor, Bronwen
- La Flamme, Anne Camille
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clozapine regulates microglia and is effective in chronic experimental autoimmune encephalomyelitis
Clozapine reduces infiltration into the CNS by targeting migration in experimental autoimmune encephalomyelitis
Amelioration of experimental autoimmune encephalomyelitis by in vivo reprogramming of macrophages using pro-resolving factors
Clozapine-induced agranulocytosis
Successful clozapine rechallenge following recurrent clozapine-associated pancreatitis: a case report
Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor
Pathogenic function of bystander-activated memory-like CD4+ T cells in autoimmune encephalomyelitis
Microglia-regulated activation of CD4+ T cells in the development of experimental autoimmune encephalomyelitis
Defective classes
Defective response of CD4+T cells to retinoic acid and TGFβ in systemic lupus erythematosus
The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice
The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
Clozapine regulates microglia and is effective in chronic experimental autoimmune encephalomyelitis
Clozapine reduces infiltration into the CNS by targeting migration in experimental autoimmune encephalomyelitis
Amelioration of experimental autoimmune encephalomyelitis by in vivo reprogramming of macrophages using pro-resolving factors
Clozapine-induced agranulocytosis
Successful clozapine rechallenge following recurrent clozapine-associated pancreatitis: a case report
Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor
Pathogenic function of bystander-activated memory-like CD4+ T cells in autoimmune encephalomyelitis
Microglia-regulated activation of CD4+ T cells in the development of experimental autoimmune encephalomyelitis
Defective classes
Defective response of CD4+T cells to retinoic acid and TGFβ in systemic lupus erythematosus
The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice
The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
Clozapine regulates microglia and is effective in chronic experimental autoimmune encephalomyelitis
Clozapine reduces infiltration into the CNS by targeting migration in experimental autoimmune encephalomyelitis
Amelioration of experimental autoimmune encephalomyelitis by in vivo reprogramming of macrophages using pro-resolving factors
Clozapine-induced agranulocytosis
Successful clozapine rechallenge following recurrent clozapine-associated pancreatitis: a case report
Clinical and Histopathological Amelioration of Experimental Autoimmune Encephalomyelitis by AAV Vectors Expressing a Soluble Interleukin-23 Receptor
Pathogenic function of bystander-activated memory-like CD4+ T cells in autoimmune encephalomyelitis
Microglia-regulated activation of CD4+ T cells in the development of experimental autoimmune encephalomyelitis
Defective classes
Defective response of CD4+T cells to retinoic acid and TGFβ in systemic lupus erythematosus
The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice